Fred Ma, M.D.

Senior Medical Officer

Dr. Ma is a medical executive with over 26 years’ experience overseeing the strategic direction of pharmaceutical, biomedical, and medical device production. Currently he is the Chief Medical Officer at RMS Medical Products, Inc. His fields of expertise are in CNS, oncology, anti-inflammatory, anti-infectious, anti-fungal, wound healing, In vitro diagnostic, and other related disciplinary areas.

Dr. Ma has advised top policy makers from the Food and Drug Administration (FDA), Center for Disease Control (CDC) as well as global regulatory agencies (e.g. EMA, WHO, Health Canada, TGA, PMDA, CFDA, etc.).

Dr. Ma also successfully adopted an advanced surgical method along with the device for cervical vertebral decompression, fusions on disc herniation, was one of the first tier of neurosurgeons in China to introduce stereotactic neurosurgery to treat functional neuro-disorders, including epilepsy, Parkinson Disease, trigeminal neuralgia, and hemi-facial spasm and served as principal investigator for a WHO clinical research project at Tokyo University Hospital of Tokyo, Japan for malignant brain tumor clinical research (a large Phase III/IV study) – “Effects of Simultaneous Chemotherapy and Radiation on Malignant Gliaoma”.

Dr. Ma received his M.D. from Capital University of Medical Sciences, Beijing, his D.M.Sc. at University of Tokyo and his Ph.D. in Neuroscience from Rutgers University of New Jersey- Newark.